Drugs / PANVAC™-VF
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT00088660 | Jun 2004 → ? | malignant pancreatic neoplasm | Therion Biologics Corporation | Unknown | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | PANVAC-VF | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00088660 ↗ |
| Modality | Vaccine | “PANVAC-VF is an investigational cancer vaccine.” NCT00088660 ↗ |